Future HIV Therapy to Relaunch as Hiv Therapy

Abstract

HIV TherapyVol. 3, No. 1 Letter from the EditorFree AccessFuture HIV Therapy to relaunch as HIV TherapyElisa ManzottiElisa ManzottiFuture Science Group, 3rd Floor, Unitec House, 2 Albert Place, Finchley Central, London, N3 1QB, UK. Search for more papers by this authorEmail the corresponding author at e.manzotti@futuremedicine.comPublished Online:23 Dec 2008https://doi.org/10.2217/17584310.3.1.1AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail Welcome to the first issue of Volume 3 – I hope that readers like the new look for the journal in 2009. In addition to a redesign of the cover, there has been some abbreviation of the title. Until this year this journal comprised part of Future Medicine’s Future journal series. Titles in the series highlight advances in molecular medicine and present this progress in a translational context and interpret those advances for the clinical setting.In recent years, the therapeutic armamentarium available in HIV/AIDS has become populated with effective antiviral approaches and combination therapies. Correspondingly, we have seen contributions to the journal adopt an increasingly clinical emphasis and reflect a more practice-based and logistics-based approach to the management of HIV/AIDs around the globe.In recognition of corresponding increased focus on contemporary clinical challenges and issues of disease management and drug resistance, Future HIV Therapy is now simply titled HIV Therapy from this January 2009 issue onward. Although, substantial advances in the development of antiretroviral drugs and clinical management are being achieved, many research challenges remain, and the journal will continue to address progress in ongoing research.We are always interested in proposals and suggestions for future coverage in HIV Therapy. In the first instance, a working title and very brief outline together with anticipated submission date help us to assess suitable and schedule appropriately. We are also encouraging authors to publish their clinical study results within HIV Therapy and share with our readers their experience in implementing effective programs of therapy. Original research and review articles are all subject to peer review, with three independent assessments per article. Coming issues will continue to deliver the commentary, analysis and new and views that readers have previously enjoyed.We hope that you enjoy this more ‘rounded’ approach to our coverage over coming issues and welcome your input and feedback about the journal at any time.FiguresReferencesRelatedDetails Vol. 3, No. 1 Follow us on social media for the latest updates Metrics History Published online 23 December 2008 Published in print January 2009 Information© Future Medicine LtdPDF download